Reliability and Validity of Online Cognitive Assessments

NCT ID: NCT02382393

Last Updated: 2015-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1152 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the concurrent validity (correlation coefficient of scores at 1 time point) between the Brain Performance Test (BPT, Lumos Labs, Inc.) and a validated third party computerized assessment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each subject will complete two sessions, each approximately 1 hour in total duration, approximately 2 weeks apart for a total duration of participation of 2 hours over 2 weeks

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BPT, Computerized Assessment

Participants will first take the Brain Performance Test (BPT) and then a third party validated assessment battery.

Group Type EXPERIMENTAL

Brain Performance Test (BPT, Lumos Labs, Inc)

Intervention Type OTHER

A brief, repeatable, online battery of cognitive assessments used to measure functioning in five cognitive domains across time.

Computerized Assessment

Intervention Type OTHER

a validated, computerized cognitive assessment tool

Computerized Assessment, BPT

Participants will take a third party validated assessment battery and then the Brain Performance Test (BPT).

Group Type EXPERIMENTAL

Brain Performance Test (BPT, Lumos Labs, Inc)

Intervention Type OTHER

A brief, repeatable, online battery of cognitive assessments used to measure functioning in five cognitive domains across time.

Computerized Assessment

Intervention Type OTHER

a validated, computerized cognitive assessment tool

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brain Performance Test (BPT, Lumos Labs, Inc)

A brief, repeatable, online battery of cognitive assessments used to measure functioning in five cognitive domains across time.

Intervention Type OTHER

Computerized Assessment

a validated, computerized cognitive assessment tool

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Electronically signed informed consent
* 18 years of age or older
* Native English-Speaker
* Consistent access to a computer with stable internet connection

Exclusion Criteria

* Under 18 years of age
* Native language other than English
* Visual impairment that impedes computer use
* Has taken a cognitive assessment or done cognitive training in the past year
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lumos Labs, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Glenn Morrison, PhD

Role: PRINCIPAL_INVESTIGATOR

Lumos Labs, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lumos Labs, Inc.

San Francisco, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

https://lumosity.com/landing?refer=8838

Click here for more information about joining this study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LL002(p)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.